Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation
暂无分享,去创建一个
[1] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[2] D. Conway,et al. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors , 2022, British Dental Journal.
[3] R. Chauhan,et al. A Study of Head and Neck Cancer Patients with Reference to Tobacco Use, Gender, and Subsite Distribution , 2022, South Asian journal of cancer.
[4] V. Singh,et al. Regular Intake of Green Tea Polyphenols Suppresses the Development of Nonmelanoma Skin Cancer through miR-29-Mediated Epigenetic Modifications , 2022, Journal of clinical medicine.
[5] C. R. Leemans,et al. Head and neck squamous cell carcinoma , 2020, Nature Reviews Disease Primers.
[6] P. Padma,et al. Epigenetic alterations in cancer. , 2020, Frontiers in bioscience.
[7] M. Shrime,et al. Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[8] T. Ushijima,et al. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk , 2019, npj Precision Oncology.
[9] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[10] G. Akkoyunlu,et al. DNMT1, DNMT3A and DNMT3B proteins are differently expressed in mouse oocytes and early embryos , 2017, Journal of Molecular Histology.
[11] S. Katiyar,et al. Honokiol inhibits ultraviolet radiation-induced immunosuppression through inhibition of ultraviolet-induced inflammation and DNA hypermethylation in mouse skin , 2017, Scientific Reports.
[12] Jie Xu,et al. DNA methyltransferases and their roles in tumorigenesis , 2017, Biomarker Research.
[13] Peter A. Jones,et al. Epigenetic Determinants of Cancer. , 2016, Cold Spring Harbor perspectives in biology.
[14] Zigang Dong,et al. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer , 2016, EBioMedicine.
[15] Shery Jacob,et al. A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.
[16] Andrew P. Feinberg,et al. DNA methylation is stable during replication and cell cycle arrest , 2015, Scientific Reports.
[17] A. Hussain,et al. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. , 2015, Oncology reports.
[18] E M Goloni-Bertollo,et al. Methylation as a biomarker for head and neck cancer. , 2014, Oral oncology.
[19] M. Quon,et al. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate , 2014, Redox biology.
[20] S. Katiyar,et al. Prostaglandin E2 Promotes UV radiation-induced immune suppression through DNA hypermethylation. , 2013, Neoplasia.
[21] N. Rhind,et al. Signaling pathways that regulate cell division. , 2012, Cold Spring Harbor perspectives in biology.
[22] S. Katiyar,et al. Epigenetic Alterations in Ultraviolet Radiation‐Induced Skin Carcinogenesis: Interaction of Bioactive Dietary Components on Epigenetic Targets † , 2012, Photochemistry and photobiology.
[23] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[24] J. Issa,et al. Targeting DNA Methylation , 2009, Clinical Cancer Research.
[25] B. Emerson,et al. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. , 2009, Molecular cell.
[26] Mette Jensen,et al. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper , 2008, BMC Medical Imaging.
[27] R. Place,et al. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. , 2008, Cancer research.
[28] J. Berletch,et al. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG , 2008, Journal of cellular biochemistry.
[29] M. Blasco,et al. Cellular Senescence in Cancer and Aging , 2007, Cell.
[30] E. Auerkari. Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. , 2006, Oral oncology.
[31] Yi Sun,et al. Reversal of Hypermethylation and Reactivation of p16INK4a, RARβ, and MGMT Genes by Genistein and Other Isoflavones from Soy , 2005, Clinical Cancer Research.
[32] Shou‐Tung Chen,et al. Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer. , 2004, Anticancer research.
[33] Ni Ai,et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.
[34] J. Go. Methylation Analysis of Cyclin-Dependent Kinase Inhibitor Genes in Primary Gastrointestinal Lymphomas , 2003, Modern Pathology.
[35] M. Robert,et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.
[36] Gary K. Beauchamp,et al. Food Intake, Water Intake, and Drinking Spout Side Preference of 28 Mouse Strains , 2002, Behavior genetics.
[37] E. Nabel. CDKS and CKIS: Molecular targets for tissue remodelling , 2002, Nature Reviews Drug Discovery.
[38] C. Plass,et al. Methylation matters , 2001, Journal of medical genetics.
[39] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[40] Rudolf Jaenisch,et al. Role for DNA methylation in genomic imprinting , 1993, Nature.
[41] S. Baylin,et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. , 1993, Journal of the National Cancer Institute.
[42] Robert L. Tanguay,et al. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. , 1990, Genes & development.